« Previous
Next »
Titles
- Aducanumab for Alzheimer’s disease: effectiveness and value1
- COVID-19: potency assay considerations for monoclonal antibodies and other therapeutic proteins targeting SARS-CoV-2 infectivity1
- Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry1
- JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: final policy recommendations1
- Monoclonal antibodies in renal research1
- Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report1